Q2 Solutions, an industry leader in clinical trial laboratory services, offers drug development services to assist pharmaceutical companies in developing assays and validated bioanalytical methods to support candidate identification and characterization. With extensive expertise in discovery and LC/MS bioanalysis, our platforms enable various aspects of ADME and pharmacokinetic (PK) testing. Balancing the promise of emerging technologies with the current needs of our clients, Q2 Solutions excels at large-scale screening using in-house or client-customized protocols with rapid turnaround.
With bioanalytical labs in the United States and China, our team utilizes a harmonized approach to support all phases of global clinical trials. To meet significant demands, Q2 Solutions also has the bioanalytical capabilities to support the largest pharmaceutical, specialty, and biotechnology companies around the globe. By leveraging the clinical trial expertise of IQVIA coupled with our vast laboratory network, we offer a comprehensive solution to support testing across the entire drug development continuum.
ImmunXperts, a Q2 Solutions Company, offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment or by saving time and money through custom assay development. In collaboration with our scientific advisors and international partners, ImmunXperts offers access to a unique team of seasoned immunology experts. ImmunXperts provides a comprehensive package, allowing you to outsource the full immunology assessment, or to cherry-pick the solutions or technologies needed/that fit your exact requirements.